Search Within

Marc Rosenblum

  1. "Dermatology Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Department of Medicine (7)
  2. Department of Pathology and Laboratory Medicine (7)
  3. Dermatology (7)
  4. Dermatology Service (7)
  5. Division of Subspecialty Medicine (7)
  6. Survivorship Research (7)

More Groups

People
  1. Benjamin Durham (4)
  2. Eli Diamond (4)
  3. Jasmine Francis (4)
  4. Kseniya Petrova-Drus (4)
  5. Mariko Yabe (4)
  6. Mario Lacouture (4)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2019 (1)
  6. 2014 (1)
Publications
  1. Pediatric Blood and Cancer (2)
  2. Pediatric Dermatology (2)
  3. British Journal of Haematology (1)
  4. Journal of Clinical Oncology (1)
  5. Neuro-Oncology (1)
Publishers
  1. Blackwell Scientific Publications (2)
  2. Wiley Periodicals, Inc (2)
  3. American Society of Clinical Oncology (1)
  4. John Wiley & Sons (1)
  5. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding
    Journal Article

    Sener, U.; Elmore, K.; Jayaseelan, K.; Porter, J.; Marghoob, A.; Rosenblum, M. K.; Haque, S.; Khakoo, Y.
    Pediatric Dermatology (2021)

    Fulltext@MSK | Save
  • Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression
    Journal Article

    Schaff, L. R.; Marghoob, A.; Rosenblum, M. K.; Meyer, R.; Khakoo, Y.
    Pediatric Dermatology (2019)

    Fulltext@MSK | Save
  • Case report: 2 patients with neurocutaneous melanocytosis harboring somatic nras gene mutations
    Meeting Abstract

    Khakoo, Y.; Pratilas, C.; Marghoob, A.; Berger, M.; Hollmann, T.; Rosenblum, M.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save